Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
350 hedge funds and large institutions have $1.99B invested in Avanos Medical in 2017 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 95 increasing their positions, 109 reducing their positions, and 31 closing their positions.
106% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 31
10% more funds holding
Funds holding: 319 → 350 (+31)
4% more capital invested
Capital invested by funds: $1.91B → $1.99B (+$70.6M)
0.94% more ownership
Funds ownership: 90.82% → 91.76% (+0.94%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
13% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 109
16% less call options, than puts
Call options by funds: $1.78M | Put options by funds: $2.12M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Channing Capital Management
Chicago,
Illinois
|
+$26.3M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$20M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$8.53M |
| 4 |
Morgan Stanley
New York
|
+$7.52M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$13.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$12.9M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$7.29M |
| 4 |
Charles Schwab
San Francisco,
California
|
-$5.89M |
| 5 |
GAM
Gotham Asset Management
New York
|
-$5.53M |
AVNS Hedge Fund Activity: Q4 2017 in Review
350 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2017, worth a combined $1.99B — up 3.7% from $1.91B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new AVNS positions and 31 closed out — a net gain of 33 holders — while 95 added to existing stakes and 109 trimmed.
The largest buyer was Channing Capital Management, opening a new position worth an estimated $26.3M. The largest seller was BlackRock, cutting an estimated $13.5M.
- 350 institutional investors held Avanos Medical (AVNS) as of Q4 2017, up from 319 in Q3 2017.
- Funds reported $1.99B of Avanos Medical stock for Q4 2017, up 3.7% quarter-over-quarter.
- 64 funds opened new Avanos Medical positions in Q4 2017 and 31 closed out, a net change of +33 holders.
- The largest Avanos Medical buyer in Q4 2017 was Channing Capital Management, an estimated $26.3M added.
- The largest Avanos Medical seller in Q4 2017 was BlackRock, an estimated $13.5M sold.
Based on aggregated 13F filings for Q4 2017.